Forte Biosciences Files 8-K on Security Holder Vote Matters
Ticker: FBRX · Form: 8-K · Filed: May 30, 2025 · CIK: 1419041
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
Related Tickers: FBRX
TL;DR
Forte Biosciences (FBRX) is holding a vote for shareholders.
AI Summary
On May 29, 2025, Forte Biosciences, Inc. filed an 8-K report detailing a submission of matters to a vote of security holders. The company, formerly known as Tocagen Inc., is incorporated in Delaware and has its principal executive offices in Dallas, Texas.
Why It Matters
This filing indicates that Forte Biosciences is engaging its security holders in a decision-making process, which could impact the company's future direction or governance.
Risk Assessment
Risk Level: low — The filing is a routine procedural report regarding a vote of security holders and does not disclose any immediate financial or operational risks.
Key Players & Entities
- Forte Biosciences, Inc. (company) — Registrant
- Tocagen Inc. (company) — Former company name
- Delaware (jurisdiction) — State of incorporation
- Dallas, Texas (location) — Principal executive offices
- May 29, 2025 (date) — Date of earliest event reported
FAQ
What specific matters are being submitted for a vote of security holders?
The filing does not specify the exact matters to be voted on, only that a submission of matters to a vote of security holders is being reported.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on May 29, 2025.
What is the former name of Forte Biosciences, Inc.?
The former name of Forte Biosciences, Inc. was Tocagen Inc.
In which state is Forte Biosciences, Inc. incorporated?
Forte Biosciences, Inc. is incorporated in Delaware.
What is the business address of Forte Biosciences, Inc.?
The business address is 3060 Pegasus Park Drive, Building 6, Dallas, Texas 75247.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 30, 2025 regarding Forte Biosciences, Inc. (FBRX).